Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma
Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abn...
Gespeichert in:
| Veröffentlicht in: | Internal Medicine 2016, Vol.55(6), pp.635-638 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 638 |
|---|---|
| container_issue | 6 |
| container_start_page | 635 |
| container_title | Internal Medicine |
| container_volume | 55 |
| creator | Hishikari, Keiichi Kuwahara, Taishi Kimura, Shigeki Hikita, Hiroyuki Takahashi, Atsushi Isobe, Mitsuaki |
| description | Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abnormal findings. Scintigraphy and a lymph node biopsy led to a diagnosis of PCL. After the start of chemotherapy, AF was converted to atrial tachycardia prior to sinus rhythm with a first-degree atrioventricular block, which was finally restored to a normal sinus rhythm. PCL is only rarely encountered, but it should be included in the differential diagnosis as a possible cause of AF, and such AF could be reversible if the patient can be treated in a timely manner. |
| doi_str_mv | 10.2169/internalmedicine.55.5851 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1794501535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1794501535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-ab772e36e5abb1eb1dd97386dc2caa4fb3023aecf4ddc4d9f647b4b64ead14883</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EokvhKyAfuWQb_0vs43ZFodIKEIKzNbYnrCsnWexs0X570qbsAXHgMnN4v3kz9iOEsnrNWWOu4jBhHiD1GKKPA66VWiut2DOyYkKaquVCPSer2jBd8blckFel3NW10K3hL8kFb4yWtWYrYr_iPeYSXUK6mXKERG-iyzElmOI40F9x2tPrDOHkIYcIdFPK6CNMGBbtS4495BPdPsqeXldbTInuTv1hP_bwmrzoIBV889Qvyfeb99-2H6vd5w-3282u8kqZqQLXthxFgwqcY-hYCKYVugmeewDZOVFzAeg7GYKXwXSNbJ10jUQITGotLsm7xfeQx59HLJPtY_HzJTDgeCyWtUaqmimh_gNtpeLacD6jekF9HkvJ2NnD8lzLavuQhP07CauUfUhiHn37tOXoZvE8-OfrZ-DTAtyVCX7gGYA8RZ_wn87No_2y4Qz6PWSLg_gNIUiouw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1774528922</pqid></control><display><type>article</type><title>Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Hishikari, Keiichi ; Kuwahara, Taishi ; Kimura, Shigeki ; Hikita, Hiroyuki ; Takahashi, Atsushi ; Isobe, Mitsuaki</creator><creatorcontrib>Hishikari, Keiichi ; Kuwahara, Taishi ; Kimura, Shigeki ; Hikita, Hiroyuki ; Takahashi, Atsushi ; Isobe, Mitsuaki</creatorcontrib><description>Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abnormal findings. Scintigraphy and a lymph node biopsy led to a diagnosis of PCL. After the start of chemotherapy, AF was converted to atrial tachycardia prior to sinus rhythm with a first-degree atrioventricular block, which was finally restored to a normal sinus rhythm. PCL is only rarely encountered, but it should be included in the differential diagnosis as a possible cause of AF, and such AF could be reversible if the patient can be treated in a timely manner.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.55.5851</identifier><identifier>PMID: 26984081</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject><![CDATA[Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; atrial fibrillation ; Atrial Fibrillation - drug therapy ; Atrial Fibrillation - etiology ; Atrial Fibrillation - physiopathology ; Atrioventricular Block - complications ; Atrioventricular Block - drug therapy ; Bradycardia - drug therapy ; Bradycardia - etiology ; Bradycardia - physiopathology ; chemotherapy ; Cyclophosphamide - administration & dosage ; diffuse large B-cell lymphoma ; Doxorubicin - administration & dosage ; Doxorubicin - analogs & derivatives ; Dyspnea - etiology ; Echocardiography ; Female ; Heart Neoplasms - complications ; Heart Neoplasms - diagnosis ; Heart Neoplasms - drug therapy ; Humans ; Lymphoma, B-Cell - complications ; Lymphoma, B-Cell - diagnosis ; Lymphoma, B-Cell - drug therapy ; Middle Aged ; Prednisolone - administration & dosage ; primary cardiac lymphoma ; Radionuclide Imaging ; Rituximab - administration & dosage ; Tomography, X-Ray Computed ; Treatment Outcome ; Vincristine - administration & dosage]]></subject><ispartof>Internal Medicine, 2016, Vol.55(6), pp.635-638</ispartof><rights>2016 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-ab772e36e5abb1eb1dd97386dc2caa4fb3023aecf4ddc4d9f647b4b64ead14883</citedby><cites>FETCH-LOGICAL-c559t-ab772e36e5abb1eb1dd97386dc2caa4fb3023aecf4ddc4d9f647b4b64ead14883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26984081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hishikari, Keiichi</creatorcontrib><creatorcontrib>Kuwahara, Taishi</creatorcontrib><creatorcontrib>Kimura, Shigeki</creatorcontrib><creatorcontrib>Hikita, Hiroyuki</creatorcontrib><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><title>Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abnormal findings. Scintigraphy and a lymph node biopsy led to a diagnosis of PCL. After the start of chemotherapy, AF was converted to atrial tachycardia prior to sinus rhythm with a first-degree atrioventricular block, which was finally restored to a normal sinus rhythm. PCL is only rarely encountered, but it should be included in the differential diagnosis as a possible cause of AF, and such AF could be reversible if the patient can be treated in a timely manner.</description><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>atrial fibrillation</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Atrial Fibrillation - etiology</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrioventricular Block - complications</subject><subject>Atrioventricular Block - drug therapy</subject><subject>Bradycardia - drug therapy</subject><subject>Bradycardia - etiology</subject><subject>Bradycardia - physiopathology</subject><subject>chemotherapy</subject><subject>Cyclophosphamide - administration & dosage</subject><subject>diffuse large B-cell lymphoma</subject><subject>Doxorubicin - administration & dosage</subject><subject>Doxorubicin - analogs & derivatives</subject><subject>Dyspnea - etiology</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Heart Neoplasms - complications</subject><subject>Heart Neoplasms - diagnosis</subject><subject>Heart Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Lymphoma, B-Cell - complications</subject><subject>Lymphoma, B-Cell - diagnosis</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Middle Aged</subject><subject>Prednisolone - administration & dosage</subject><subject>primary cardiac lymphoma</subject><subject>Radionuclide Imaging</subject><subject>Rituximab - administration & dosage</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Vincristine - administration & dosage</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxS0EokvhKyAfuWQb_0vs43ZFodIKEIKzNbYnrCsnWexs0X570qbsAXHgMnN4v3kz9iOEsnrNWWOu4jBhHiD1GKKPA66VWiut2DOyYkKaquVCPSer2jBd8blckFel3NW10K3hL8kFb4yWtWYrYr_iPeYSXUK6mXKERG-iyzElmOI40F9x2tPrDOHkIYcIdFPK6CNMGBbtS4495BPdPsqeXldbTInuTv1hP_bwmrzoIBV889Qvyfeb99-2H6vd5w-3282u8kqZqQLXthxFgwqcY-hYCKYVugmeewDZOVFzAeg7GYKXwXSNbJ10jUQITGotLsm7xfeQx59HLJPtY_HzJTDgeCyWtUaqmimh_gNtpeLacD6jekF9HkvJ2NnD8lzLavuQhP07CauUfUhiHn37tOXoZvE8-OfrZ-DTAtyVCX7gGYA8RZ_wn87No_2y4Qz6PWSLg_gNIUiouw</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Hishikari, Keiichi</creator><creator>Kuwahara, Taishi</creator><creator>Kimura, Shigeki</creator><creator>Hikita, Hiroyuki</creator><creator>Takahashi, Atsushi</creator><creator>Isobe, Mitsuaki</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160101</creationdate><title>Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma</title><author>Hishikari, Keiichi ; Kuwahara, Taishi ; Kimura, Shigeki ; Hikita, Hiroyuki ; Takahashi, Atsushi ; Isobe, Mitsuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-ab772e36e5abb1eb1dd97386dc2caa4fb3023aecf4ddc4d9f647b4b64ead14883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>atrial fibrillation</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Atrial Fibrillation - etiology</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrioventricular Block - complications</topic><topic>Atrioventricular Block - drug therapy</topic><topic>Bradycardia - drug therapy</topic><topic>Bradycardia - etiology</topic><topic>Bradycardia - physiopathology</topic><topic>chemotherapy</topic><topic>Cyclophosphamide - administration & dosage</topic><topic>diffuse large B-cell lymphoma</topic><topic>Doxorubicin - administration & dosage</topic><topic>Doxorubicin - analogs & derivatives</topic><topic>Dyspnea - etiology</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Heart Neoplasms - complications</topic><topic>Heart Neoplasms - diagnosis</topic><topic>Heart Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Lymphoma, B-Cell - complications</topic><topic>Lymphoma, B-Cell - diagnosis</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Middle Aged</topic><topic>Prednisolone - administration & dosage</topic><topic>primary cardiac lymphoma</topic><topic>Radionuclide Imaging</topic><topic>Rituximab - administration & dosage</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Vincristine - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hishikari, Keiichi</creatorcontrib><creatorcontrib>Kuwahara, Taishi</creatorcontrib><creatorcontrib>Kimura, Shigeki</creatorcontrib><creatorcontrib>Hikita, Hiroyuki</creatorcontrib><creatorcontrib>Takahashi, Atsushi</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hishikari, Keiichi</au><au>Kuwahara, Taishi</au><au>Kimura, Shigeki</au><au>Hikita, Hiroyuki</au><au>Takahashi, Atsushi</au><au>Isobe, Mitsuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>55</volume><issue>6</issue><spage>635</spage><epage>638</epage><pages>635-638</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abnormal findings. Scintigraphy and a lymph node biopsy led to a diagnosis of PCL. After the start of chemotherapy, AF was converted to atrial tachycardia prior to sinus rhythm with a first-degree atrioventricular block, which was finally restored to a normal sinus rhythm. PCL is only rarely encountered, but it should be included in the differential diagnosis as a possible cause of AF, and such AF could be reversible if the patient can be treated in a timely manner.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>26984081</pmid><doi>10.2169/internalmedicine.55.5851</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0918-2918 |
| ispartof | Internal Medicine, 2016, Vol.55(6), pp.635-638 |
| issn | 0918-2918 1349-7235 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1794501535 |
| source | J-STAGE Free; MEDLINE; PubMed Central; PubMed Central Open Access |
| subjects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use atrial fibrillation Atrial Fibrillation - drug therapy Atrial Fibrillation - etiology Atrial Fibrillation - physiopathology Atrioventricular Block - complications Atrioventricular Block - drug therapy Bradycardia - drug therapy Bradycardia - etiology Bradycardia - physiopathology chemotherapy Cyclophosphamide - administration & dosage diffuse large B-cell lymphoma Doxorubicin - administration & dosage Doxorubicin - analogs & derivatives Dyspnea - etiology Echocardiography Female Heart Neoplasms - complications Heart Neoplasms - diagnosis Heart Neoplasms - drug therapy Humans Lymphoma, B-Cell - complications Lymphoma, B-Cell - diagnosis Lymphoma, B-Cell - drug therapy Middle Aged Prednisolone - administration & dosage primary cardiac lymphoma Radionuclide Imaging Rituximab - administration & dosage Tomography, X-Ray Computed Treatment Outcome Vincristine - administration & dosage |
| title | Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A41%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reversible%20Atrial%20Fibrillation%20with%20Bradycardia%20Associated%20with%20Primary%20Cardiac%20B-Cell%20Lymphoma&rft.jtitle=Internal%20Medicine&rft.au=Hishikari,%20Keiichi&rft.date=2016-01-01&rft.volume=55&rft.issue=6&rft.spage=635&rft.epage=638&rft.pages=635-638&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.55.5851&rft_dat=%3Cproquest_cross%3E1794501535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1774528922&rft_id=info:pmid/26984081&rfr_iscdi=true |